share_log

The FDA Issued Determination Letter For Mimedx's Request For Designation Noting Axiofill Does Not Meet Regulatory Classification Requirements Of A Human Cell, Tissue, Or Cellular Or Tissue-based Product

The FDA Issued Determination Letter For Mimedx's Request For Designation Noting Axiofill Does Not Meet Regulatory Classification Requirements Of A Human Cell, Tissue, Or Cellular Or Tissue-based Product

美国食品和药物管理局针对Mimedx的指定申请发布了裁决书,指出Axiofill不符合人体细胞、组织或细胞或组织类产品的监管分类要求
Benzinga ·  03/27 08:09

The FDA Issued Determination Letter For Mimedx's Request For Designation Noting Axiofill Does Not Meet Regulatory Classification Requirements Of A Human Cell, Tissue, Or Cellular Or Tissue-based Product

美国食品和药物管理局针对Mimedx的指定申请发布了裁决书,指出Axiofill不符合人体细胞、组织或细胞或组织类产品的监管分类要求

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发